ArticleThe Journal of clinical investigation2022

Targeting acetylcholine signaling modulates persistent drug tolerance in EGFR-mutant lung cancer and impedes tumor relapse.

Meng Nie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.